Parallax Volatility Advisers, L.P. Pulmonx Corp Transaction History
Parallax Volatility Advisers, L.P.
- $53.5 Billion
- Q3 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Pulmonx Corp stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 50,000 shares of LUNG stock, worth $308,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$308,000% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding LUNG
# of Institutions
124Shares Held
31MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.68MShares$35 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$23.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$14 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.4 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $230M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...